PLN877.00
1.35% day before yesterday
Warsaw, Dec 27, 04:48 pm CET
ISIN
PLTRFRM00018
Symbol
NEU

Neuca Stock price

PLN875.00
+115.00 15.13% 1M
-51.00 5.51% 6M
-35.56 3.91% YTD
+8.74 1.01% 1Y
+127.00 16.98% 3Y
+520.17 146.60% 5Y
+695.37 387.11% 10Y
Warsaw, Closing price Fri, Dec 27 2024
-14.00 1.57%
ISIN
PLTRFRM00018
Symbol
NEU
Sector

Key metrics

Market capitalization PLN3.93b
Enterprise Value PLN4.71b
P/E (TTM) P/E ratio 24.12
EV/FCF (TTM) EV/FCF 195.75
EV/Sales (TTM) EV/Sales 0.38
P/S ratio (TTM) P/S ratio 0.32
P/B ratio (TTM) P/B ratio 3.56
Dividend yield 1.66%
Last dividend (FY23) PLN14.50
Revenue growth (TTM) Revenue growth 4.49%
Revenue (TTM) Revenue PLN12.34b
EBIT (operating result TTM) EBIT PLN281.15m
Free Cash Flow (TTM) Free Cash Flow PLN24.04m
Cash position PLN346.21m
EPS (TTM) EPS PLN36.28
P/S forward 0.30
EV/Sales forward 0.36
Show more

Is Neuca a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Neuca Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Neuca forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Neuca forecast:

Buy
50%
Hold
50%

Financial data from Neuca

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
12,343 12,343
4% 4%
100%
- Direct Costs 10,912 10,912
4% 4%
88%
1,430 1,430
4% 4%
12%
- Selling and Administrative Expenses 1,029 1,029
3% 3%
8%
- Research and Development Expense - -
-
-
401 401
17% 17%
3%
- Depreciation and Amortization 120 120
-
1%
EBIT (Operating Income) EBIT 281 281
22% 22%
2%
Net Profit 161 161
27% 27%
1%

In millions PLN.

Don't miss a Thing! We will send you all news about Neuca directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

NEUCA SA engages in the wholesale of pharmaceutical products. It operates through the following segments: Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials, and Telemedicine. The Pharmaceutical Wholesale segment provides medical products for pharmacies. The Own Brands segment comprises market launching of pharmaceutical products under own brand. The Outpatient Care Clinics, Clinical Trials, and Telemedicine segment activities include general medical practice, clinical trials, and telemedicine. The company was founded by Kazimierz Michal Herba in 1990 and is headquartered in Torun, Poland.

Head office Poland
CEO Piotr Sucharski
Employees 4,633
Founded 1990
Website www.neuca.pl

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today